Is Northern Dynasty Minerals a Good Mining Stock to Own?

NYSE: NAK | Northern Dynasty Minerals, Ltd.  News, Ratings, and Charts

NAK – Canada-based copper mining company Northern Dynasty Minerals’ (NAK) Pebble Project has attracted significant investor attention because of its potential to boost the production of metals used in green technology. But given that politically unfavorable circumstances have put the project’s future in jeopardy, is it worth betting on the stock now? Read on.

Based in Vancouver, Canada, mineral exploration company Northern Dynasty Minerals Ltd.’s (NAK) principal mineral property—the Pebble project—represents the most significant underdeveloped copper and gold resource in the world. And because the Biden administration’s renewable and low-carbon energy targets are expected to drive unprecedented demand for copper, the company is well-positioned to benefit. 

However, NAK’s shares fell 10.3% in price on Monday after the U.S. Environmental Protection Agency (EPA) announced its decision to file a motion to remand its July 2019 withdrawal notice concerning Alaska’s Pebble Project. In addition, the stock is trading 64% below its 52-week high of $1.26, indicating short-term bearishness.

While its Pebble Project initiative could boost green power and electrification technologies, ongoing legal challenges and NAK’s faltering financials could make investors nervous.

Here’s what we think could influence NAK’s performance in the near term:

EPA Decision Could Hamper the Pebble Project

Last week, the Biden administration said it would relaunch a process for permanently protecting the Alaskan watershed from the development of the Pebble Mine project. EPA Administrator Michael Regan said, “The Bristol Bay Watershed is an Alaskan treasure that underscores the critical value of clean water in America.” If the Alaska federal district court grants the request to vacate the 2019 decision to remove the previously issued protection of the Bristol Bay watershed, it will restore the EPA’s Clean Water Act Section 404 review process. This could put NAK’s Pebble Project’s future in jeopardy  and mar the company’s growth prospects.

At-the-Market Offering of Shares

In June, NAK entered an At-the-Market Offering Agreement with H.C. Wainwright & Co. to sell up to $14.5 million of the company’s common shares. It plans to use the offering’s net proceeds to fund its work on the Pebble Project and to prepare  engineering reports to appeal the Record of Decision by the United States Army Corps of Engineers, and for general corporate purposes. However, the offering could negatively impact its stock price because it will lead to the dilution of existing shares.

Lackluster Financials

NAK has not generated any revenue but its share-based compensation for the second quarter, ended June 30, 2021, rose 109.1% year-over-year to CAD1.29 million ($1.02 million). Also, its loss from operating activities came in at CAD9.03 million ($7.13 million), while net loss stood at CAD9.22 million ($7.29 million). Furthermore,  NAK’s loss per share amounted to $0.02 for the quarter. And its net decrease in cash and cash equivalents totaled CAD5.11 million ($4.04 million) for the six months ended June 30, 2021. Its  net cash from financing activities declined 53.7% year-over-year to CAD10.85 million ($8.57 million) over this period.

Its trailing-12-month ROE, ROA, and ROTC are negative 37%, 33.7%, and 22.2%, respectively. Also, its trailing-12-month cash from operations stood at  negative $41.16 million.

Unfavorable POWR Ratings

NAK has an overall F rating, which translates to a Strong Sell in our POWR Ratings system. The POWR Ratings are calculated by considering 118 different factors, with each factor weighted to an optimal degree. 

Our proprietary rating system also evaluates each stock based on eight different categories. NAK has an F grade for Quality. The stock’s negative profit margin is reflected in this grade.

It also has a C grade for Growth, which is consistent with the stock’s bleak growth prospects.

In terms of Stability Grade, NAK has a D. This indicates that the stock is more volatile than its peers.

Beyond the grades we’ve highlighted, one can check out additional NAK ratings for Sentiment, Value, and Momentum here.

Of the 39 stocks in the D-rated Industrial – Metals industry, NAK is ranked #37.

Bottom Line

Even though NAK’s Pebble Project remains an important domestic source to meet the country’s lower carbon emission goals, the Biden administration’s opposition to the mine to protect Bristol Bay, and the EPA’s efforts to vacate its  previously announced 2019 notice that ended the review process, could threaten the company’s growth. Meanwhile, its weak balance sheet and significant cash burn could pose a risk to the stock. So, we think the stock is best avoided now.

How Does Northern Dynasty Minerals (NAK) Stack Up Against its Peers?

While NAK has an overall POWR Rating of F, one  might want to consider taking a look at its industry peers, Ryerson Holding Corporation (RYI), Vale S.A. ADR (VALE), and Atkore International Group Inc. (ATKR), which have an A (Strong Buy) rating.

Note that ATKR is one of the few stocks handpicked by our Chief Growth Strategist, Jaimini Desai, currently in the POWR Growth portfolio. Learn more here.


NAK shares fell $0.00 (-1.06%) in premarket trading Tuesday. Year-to-date, NAK has gained 39.75%, versus a 20.15% rise in the benchmark S&P 500 index during the same period.


About the Author: Imon Ghosh


Imon is an investment analyst and journalist with an enthusiasm for financial research and writing. She began her career at Kantar IMRB, a leading market research and consumer consulting organization. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
NAKGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


:  |  News, Ratings, and Charts

How to Beat the Market the Rest of the Year?

The easy gains that came at the start of this new bull market are fading away fast. In fact the stock market (SPY) has become quite volatile with gains harder to come by. Gladly there are solutions as will be shared in this commentary to get you on the right path to outperform the market through the end of 2021 and beyond. Read the rest below...

:  |  News, Ratings, and Charts

2022 Stock Market Outlook

The stock market (SPY) has continued on a bullish path in 2021. Will that continue in 2022? And what could happen to awaken the bear market from hibernation? 40 year investment veteran Steve Reitmeister explores this and more in this early edition of his 2022 Stock Market Outlook. Read on for full details below...

:  |  News, Ratings, and Charts

3 Cheap Healthcare Stocks to Buy Right Now

Healthcare stocks saw renewed interest due to the onset of the pandemic, but It’s not only COVID that is driving returns. The Baby Boomer generation is getting older, which is resulting in increased demand for healthcare products and services. That’s why investors should consider adding undervalued healthcare stocks such as Ironwood Pharmaceuticals, Inc. (IRWD), Nu Skin Enterprises, Inc. (NUS), and Bristol-Myers Squibb Co. (BMY) to their portfolio.

:  |  News, Ratings, and Charts

3 Value Stocks to Buy While You Still Can

After outperforming from last fall into the spring, value stocks have been overtaken by growth stocks, but that is expected to change as the economic recovery continues. So, now is the time to start putting your money to work in undervalued companies that offer the potential for strong returns such as Gilead Sciences Inc. (GILD), HP Inc. (HPQ), and CNH Industrial N.V. (CNHI).

:  |  News, Ratings, and Charts

3 Cheap Healthcare Stocks to Buy Right Now

Healthcare stocks saw renewed interest due to the onset of the pandemic, but It’s not only COVID that is driving returns. The Baby Boomer generation is getting older, which is resulting in increased demand for healthcare products and services. That’s why investors should consider adding undervalued healthcare stocks such as Ironwood Pharmaceuticals, Inc. (IRWD), Nu Skin Enterprises, Inc. (NUS), and Bristol-Myers Squibb Co. (BMY) to their portfolio.

Read More Stories

More Northern Dynasty Minerals, Ltd. (NAK) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All NAK News